Browse the 369 posters accepted to this year's symposium. Search by author name, by keyword in the title, or narrow to a category. Click any keyword chip on a result to pivot to a related search.
-
51 7.73
Distinct IL-1/VEGF-Dominant Phenotype in IL-6-Refractory Multicentric Castleman Disease: A Pooled Matched Analysis of Anakinra versus IL-6 Blockade
-
54 7.17
Therapeutic Architecture Rather Than Population Differences Drives Front-Line Outcomes in T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Comparison-Specific Pooled Analysis of Rituximab-Era Cohorts
-
52 6.4
Steroid Non-Response Predicts IL-6 Blockade Failure and Defines a Non-IL-6-Dominant Inflammatory Subset in TAFRO Syndrome: A Pooled Patient-Level Analysis
-
55 6.4
Differential Toxicity Patterns with Bispecific Antibody Monotherapy and Daratumumab-Based Combinations in Multiple Myeloma - A Pooled Analysis
-
64 4.9
Clinical Predictors of Remission in TAFRO Syndrome: A Pooled Meta Analysis of 70 Published Cases